New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Clinical trial: Some sarcoma patients improve with T cell immunotherapy

Clinical trial: Some sarcoma patients improve with T cell immunotherapy

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisCredit: Pixabay from PexelsA clinical trial led by researchers at Washington University School of Medicine in St. L
Oncology March 30,2024
Clinical trial: Some sarcoma patients improve with T cell immunotherapy

Clinical trial: Some sarcoma patients improve with T cell immunotherapy

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisCredit: Pixabay from PexelsA clinical trial led by researchers at Washington University School of Medicine in St. L
Oncology March 30,2024
Research points to an immunotherapy to overcome resistant leukemia

Research points to an immunotherapy to overcome resistant leukemia

by University of ZurichTP53 deficiency in AML leads to resistance against CAR T-cell-mediated killing that can be overcome by targeting the mevalonate and Wnt pathways. Credit:EMBO Molecula
Oncology March 30,2024
Research points to an immunotherapy to overcome resistant leukemia

Research points to an immunotherapy to overcome resistant leukemia

by University of ZurichTP53 deficiency in AML leads to resistance against CAR T-cell-mediated killing that can be overcome by targeting the mevalonate and Wnt pathways. Credit:EMBO Molecula
Oncology March 30,2024
New research highlights combining prostate MRI with a blood test to avoid unnecessary prostate biopsies

New research highlights combining prostate MRI with a blood test to avoid unnecessary prostate biopsies

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainMRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new rese
Oncology March 30,2024
New research highlights combining prostate MRI with a blood test to avoid unnecessary prostate biopsies

New research highlights combining prostate MRI with a blood test to avoid unnecessary prostate biopsies

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainMRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new rese
Oncology March 30,2024
Treatment of advanced non-small cell lung cancer with driver mutations

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved
Oncology March 30,2024
Treatment of advanced non-small cell lung cancer with driver mutations

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved
Oncology March 30,2024
New alveolar soft-part sarcoma chip can mimic the microenvironment during angiogenesis

New alveolar soft-part sarcoma chip can mimic the microenvironment during angiogenesis

by Kyoto UniversityAngiogenic microenvironment of alveolar soft-part sarcoma (ASPS) in a microfluidic chip. Credit: KyotoU/Ryuji YokokawaCancer, the second leading cause of death worldwide, is mo
Oncology March 30,2024
New alveolar soft-part sarcoma chip can mimic the microenvironment during angiogenesis

New alveolar soft-part sarcoma chip can mimic the microenvironment during angiogenesis

by Kyoto UniversityAngiogenic microenvironment of alveolar soft-part sarcoma (ASPS) in a microfluidic chip. Credit: KyotoU/Ryuji YokokawaCancer, the second leading cause of death worldwide, is mo
Oncology March 30,2024
A blood test for colon cancer performed well in a study, expanding options for screening

A blood test for colon cancer performed well in a study, expanding options for screening

by Carla K. JohnsonThis image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the&nbs
Oncology March 30,2024
A blood test for colon cancer performed well in a study, expanding options for screening

A blood test for colon cancer performed well in a study, expanding options for screening

by Carla K. JohnsonThis image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the&nbs
Oncology March 30,2024
Study shows improved outcomes in hospitals accredited for rectal cancer surgery

Study shows improved outcomes in hospitals accredited for rectal cancer surgery

byAmerican College of SurgeonsCredit: Pixabay/CC0 Public DomainHospitals accredited by the American College of Surgeons (ACS) National Accreditation Program for Rectal Cancer (NAPRC) demonstrate
Oncology March 30,2024
Study shows improved outcomes in hospitals accredited for rectal cancer surgery

Study shows improved outcomes in hospitals accredited for rectal cancer surgery

byAmerican College of SurgeonsCredit: Pixabay/CC0 Public DomainHospitals accredited by the American College of Surgeons (ACS) National Accreditation Program for Rectal Cancer (NAPRC) demonstrate
Oncology March 30,2024
Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he
Oncology March 30,2024
Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he
Oncology March 30,2024
Patient-derived organoids in human cancer: A platform for fundamental research and precision medicine

Patient-derived organoids in human cancer: A platform for fundamental research and precision medicine

by Sichuan International Medical Exchange and Promotion AssociationThe GBM organoids culture process and subsequent analysis are illustrated schematically. A rapid and dependable technique has been de
Oncology March 30,2024
Patient-derived organoids in human cancer: A platform for fundamental research and precision medicine

Patient-derived organoids in human cancer: A platform for fundamental research and precision medicine

by Sichuan International Medical Exchange and Promotion AssociationThe GBM organoids culture process and subsequent analysis are illustrated schematically. A rapid and dependable technique has been de
Oncology March 30,2024
Enhanced melanoma vaccine offers improved survival for men

Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei
Oncology March 30,2024
Enhanced melanoma vaccine offers improved survival for men

Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei
Oncology March 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com